Cargando…
Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss
Autores principales: | Fearon, U, Mullan, R, Poole, R, Markham, T, FitzGerald, O, Bresnihan, B, Veale, DJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834060/ http://dx.doi.org/10.1186/ar1582 |
Ejemplares similares
-
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
por: Moran, Ellen M, et al.
Publicado: (2009) -
The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005) -
Synergistic interactions of proinflammatory cytokines with oncostatin M: implications for joint destruction
por: Cawston, T, et al.
Publicado: (2003) -
Mechanisms of cartilage matrix turnover: synergistic interactions of proinflammatory cytokines with oncostatin M in upregulating matrix metalloproteinases and ADAMTS metalloproteinases
por: Cawston, TE, et al.
Publicado: (2005) -
Synergistic interactions of proinflammatory cytokines with oncostatin M: production of active collagenases and implications for joint destruction
por: Cawston, TE
Publicado: (2004)